Investing & Market Trading Insights in Australia

Search Results

3261-3280 of 10000

Equities

April 24, 2024 14:49

Why Goldman Sachs would buy IGO and sell Mineral Resources

Major broker Goldman Sachs has released a research report outlining reasons why it thinks IGO is a buy and Minera Resources is a sell.

Carl Capolingua

Livewire Markets

April 24, 2024 14:49

Macro

April 24, 2024 14:14

The RBA should warn that it could raise rates again

High inflation reinforces that the RBA should have raised rates by more last year, in line with its peers.

Kieran Davies

Coolabah Capital

April 24, 2024 14:14

Equities

April 24, 2024 13:18

Ejector seats of investment: Harnessing liquidity risk management to avoid financial freefall

Our minimum market capitalization is US$1.5b, and we primarily invest in companies that enable us to enter or exit our target position within five trading days at 20%...

Steven Glass

Pella Funds Management

April 24, 2024 13:18

Equities

April 24, 2024 12:43

Why companies are issuing more dividends (and initiating less buybacks)

The answer lies in interest rates...

Janus Henderson

April 24, 2024 12:43

Equities

April 24, 2024 12:30

Is it time to buy the dip in global growth stocks?

According to these two experts, investors should hold their fire.

+11

Ally Selby

Livewire Markets

April 24, 2024 12:30

Macro

April 24, 2024 12:08

Australian inflation was hotter than expected. Here's why

Australian inflation has ticked up - is this a bump in the road or was the end of 2023 the bottom?

Hans Lee

Livewire Markets

April 24, 2024 12:08

Rapid Fire

April 24, 2024 11:09

The only Aussie name in Platinum's global stocks fund

Platinum Asset Management’s Clay Smolinski discusses how he’s positioned now, including 10 global stocks and 1 local name

+12

+10

Glenn Freeman

Livewire Markets

April 24, 2024 11:09

Macro

April 24, 2024 09:59

What investors should know about China's economy

A guide to making sense of China's economic data.

Janu Chan

Bitesized Economics

April 24, 2024 09:59

Equities

April 24, 2024 09:40

Investing in Pharma: The drug lifecycle

Drug development pipelines are the lifeblood of the pharmaceutical industry. It is crucial for investors to understand milestones like FDA approvals and the impact of...

CURE

Global X ETFs

April 24, 2024 09:40

Equities

April 24, 2024 09:23

Where are they now? The 10 biggest gainers in the ASX 200 last year

Have last year's heroes held their ground, or have the mighty fallen? I take a closer look in this wire.

Sara Allen

Livewire Markets

April 24, 2024 09:23

Daily Report

April 24, 2024 08:52

ASX 200 to extend bounce, strong US earnings lift the S&P 500 and Nasdaq

Get up to date on overnight market activity and the big events for the day.

The Morning Wrap

Livewire Markets

April 24, 2024 08:52

The Pitch

April 24, 2024 08:00

Why the end of a rate hiking cycle is an attractive time for this asset class

The end to hikes is appealing to many, and this investment type has a history of benefiting from the transition.

Sara Allen

Livewire Markets

April 24, 2024 08:00

Investment Theme

April 24, 2024 08:00

Private debt on the rise as investors look for income and dial down risk

A growing cohort of investors are looking to private real estate lending to provide property exposure with less volatility.

Alan Greenstein

Zagga Investments

April 24, 2024 08:00

The Pitch

April 24, 2024 07:30

The asset class growing like a mushroom in our own backyard (and how to access it)

Conditions couldn’t be riper for this asset to blossom - but you may not know what it is. Watch this episode of The Pitch to find out.

Hans Lee

Livewire Markets

April 24, 2024 07:30

Daily Report

April 23, 2024 17:53

ASX 200 logs another solid gain on takeover rumours in health and industrials, gold stocks slump again

Not one, but two potential major takeover rumours did the rounds today as Aussie stocks bounced back, well except for gold stocks, that is.

Carl Capolingua

Livewire Markets

April 23, 2024 17:53

Equities

April 23, 2024 16:18

Why we believe Telix Pharmaceuticals is an attractive investment

Uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts.

TLX

Sean Sequeira

Australian Eagle Asset Management

April 23, 2024 16:18

Equities

April 23, 2024 13:07

We all know about “Sell in May and go away”, but is it too late for 2024?

We test what a poor April means for "Sell in May and go away" and investigate when to buy back if you follow the oldest saying in markets.

Carl Capolingua

Livewire Markets

April 23, 2024 13:07

The Pitch

April 23, 2024 09:30

What you need to know about new norms for asset allocation

Is your portfolio adjusted for the modern market? All you need to know with MLC Asset Management’s Anthony Golowenko.

Sara Allen

Livewire Markets

April 23, 2024 09:30

Daily Report

April 23, 2024 08:35

ASX 200 to rise, gold stocks set to tumble, S&P 500 snaps 6-day losing streak

Get up to date on overnight market activity and the big events for the day.

The Morning Wrap

Livewire Markets

April 23, 2024 08:35

Funds

April 23, 2024 07:00

3 ETFs to take advantage of the recent market drawdown

The final instalment of The $10,000 Idea Series looks at even more opportunities in the exchange-traded product market.

+10

Hans Lee

Livewire Markets

April 23, 2024 07:00

3261-3280 of 10000

Account

Company

Search Results

Filters

Content Type

Contributor

Stock

Sort

Why Goldman Sachs would buy IGO and sell Mineral Resources

The RBA should warn that it could raise rates again

Ejector seats of investment: Harnessing liquidity risk management to avoid financial freefall

Why companies are issuing more dividends (and initiating less buybacks)

Is it time to buy the dip in global growth stocks?

Australian inflation was hotter than expected. Here's why

The only Aussie name in Platinum's global stocks fund

What investors should know about China's economy

Investing in Pharma: The drug lifecycle

Where are they now? The 10 biggest gainers in the ASX 200 last year

ASX 200 to extend bounce, strong US earnings lift the S&P 500 and Nasdaq

Why the end of a rate hiking cycle is an attractive time for this asset class

Private debt on the rise as investors look for income and dial down risk

The asset class growing like a mushroom in our own backyard (and how to access it)

ASX 200 logs another solid gain on takeover rumours in health and industrials, gold stocks slump again

Why we believe Telix Pharmaceuticals is an attractive investment

We all know about “Sell in May and go away”, but is it too late for 2024?

What you need to know about new norms for asset allocation

ASX 200 to rise, gold stocks set to tumble, S&P 500 snaps 6-day losing streak

3 ETFs to take advantage of the recent market drawdown